Supernatants of intestinal luminal contents from mice fed high‐fat diet impair intestinal motility by injuring enteric neurons and smooth muscle cells

Damage to enteric neurons and impaired gastrointestinal muscle contractions cause motility disorders in 70% of diabetic patients. It is thought that enteric neuropathy and dysmotility occur before overt diabetes, but triggers of these abnormalities are not fully known. We tested the hypothesis that intestinal contents of mice with and without high‐fat diet‐ (HFD‐) induced diabetic conditions contain molecules that impair gastrointestinal movements by damaging neurons and disrupting muscle contractions.

[1]  L. Forney,et al.  High‐fat diet–induced alterations to gut microbiota and gut‐derived lipoteichoic acid contributes to the development of enteric neuropathy , 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[2]  Sugato Banerjee,et al.  Gut microbiota in neurodegenerative disorders , 2019, Journal of Neuroimmunology.

[3]  L. Forney,et al.  Intestinal nerve cell injury occurs prior to insulin resistance in female mice ingesting a high-fat diet , 2019, Cell and Tissue Research.

[4]  R. B. Oliveira,et al.  Intestinal luminal content from high‐fat‐fed prediabetic mice changes epithelial barrier function in vitro , 2019, Life sciences.

[5]  M. Rao,et al.  Enteric nervous system manifestations of neurodegenerative disease , 2018, Brain Research.

[6]  C. Knauf,et al.  Galanin enhances systemic glucose metabolism through enteric Nitric Oxide Synthase-expressed neurons , 2018, Molecular metabolism.

[7]  Brian D. Gulbransen,et al.  The antioxidant glutathione protects against enteric neuron death in situ, but its depletion is protective during colitis. , 2018, American journal of physiology. Gastrointestinal and liver physiology.

[8]  R. Schey,et al.  Diabetes and the Small Intestine , 2017, Current Treatment Options in Gastroenterology.

[9]  B. Berger,et al.  Luminal contents from the gut of colicky infants induce visceral hypersensitivity in mice , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[10]  O. Balemba,et al.  Diet‐induced dysmotility and neuropathy in the gut precedes endotoxaemia and metabolic syndrome: the chicken and the egg revisited , 2017, The Journal of physiology.

[11]  M. Cicala,et al.  Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[12]  Dean P. Jones,et al.  Western diet induces colonic nitrergic myenteric neuropathy and dysmotility in mice via saturated fatty acid‐ and lipopolysaccharide‐induced TLR4 signalling , 2016, The Journal of physiology.

[13]  D. Fried,et al.  High-fat diet-induced obesity alters nitric oxide-mediated neuromuscular transmission and smooth muscle excitability in the mouse distal colon. , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[14]  S. Srinivasan,et al.  Intestinal Dysbiosis Contributes to the Delayed Gastrointestinal Transit in High-Fat Diet Fed Mice , 2016, Cellular and molecular gastroenterology and hepatology.

[15]  Brian D. Gulbransen,et al.  Enteric Glia Mediate Neuron Death in Colitis Through Purinergic Pathways That Require Connexin-43 and Nitric Oxide , 2015, Cellular and molecular gastroenterology and hepatology.

[16]  C. Knauf,et al.  Apelin targets gut contraction to control glucose metabolism via the brain , 2015, Gut.

[17]  J. Wasilewska,et al.  Gastrointestinal symptoms and autism spectrum disorder: links and risks – a possible new overlap syndrome , 2015, Pediatric health, medicine and therapeutics.

[18]  P. Kempler,et al.  Diabetes-Related Dysfunction of the Small Intestine and the Colon: Focus on Motility , 2015, Current Diabetes Reports.

[19]  G. Farrugia Histologic changes in diabetic gastroparesis. , 2015, Gastroenterology clinics of North America.

[20]  S. Srinivasan,et al.  Diabetic gastrointestinal motility disorders and the role of enteric nervous system: Current status and future directions , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[21]  Ashutosh Kumar,et al.  Neuroinflammation and Oxidative Stress in Diabetic Neuropathy: Futuristic Strategies Based on These Targets , 2014, International journal of endocrinology.

[22]  P. François,et al.  Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity , 2014, The ISME Journal.

[23]  Amber D. Miller,et al.  Role of innate immunity and altered intestinal motility in LPS- and MnCl2-induced intestinal intussusception in mice. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[24]  J. Shaw,et al.  Global estimates of diabetes prevalence for 2013 and projections for 2035. , 2014, Diabetes Research and Clinical Practice.

[25]  Navpreet Kaur,et al.  Diabetic peripheral neuropathy: current perspective and future directions. , 2014, Pharmacological research.

[26]  V. Mohan,et al.  Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes , 2014, Molecular and Cellular Biochemistry.

[27]  B. Olde,et al.  Enteric Neuropathy Can Be Induced by High Fat Diet In Vivo and Palmitic Acid Exposure In Vitro , 2013, PloS one.

[28]  M. Islam Animal Models of Diabetic Neuropathy: Progress Since 1960s , 2013, Journal of diabetes research.

[29]  O. Balemba,et al.  High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes , 2013, Cell and Tissue Research.

[30]  Joseph M Pappachan,et al.  Gastrointestinal complications of diabetes mellitus. , 2013, World journal of diabetes.

[31]  J. Doré,et al.  Gut microbiota and gastrointestinal health: current concepts and future directions , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[32]  J. Galligan,et al.  Impaired propulsive motility in the distal but not proximal colon of BK channel β1‐subunit knockout mice , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[33]  C. Pothoulakis,et al.  Elevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[34]  E. Benarroch,et al.  Pathological correlates of gastrointestinal dysfunction in Parkinson's disease , 2012, Neurobiology of Disease.

[35]  N. Bódi,et al.  Diabetes-related alterations in the enteric nervous system and its microenvironment. , 2012, World journal of diabetes.

[36]  S. Srinivasan,et al.  Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[37]  Ferdinando Giacco,et al.  Oxidative stress and diabetic complications. , 2010, Circulation research.

[38]  C. Jobin,et al.  High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse , 2010, PloS one.

[39]  J. Furness,et al.  Immunohistochemical analysis of neuron types in the mouse small intestine , 2008, Cell and Tissue Research.

[40]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[41]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[42]  C. Knauf,et al.  Comment on: Cani et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance: Diabetes , 2007 .

[43]  O. Melander,et al.  Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis , 2006, Diabetologia.

[44]  S. Srinivasan,et al.  GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. , 2006, The Journal of clinical investigation.

[45]  Simon Smyth,et al.  Diabetes and obesity: the twin epidemics , 2006, Nature Medicine.

[46]  Daniel J Klionsky,et al.  Sera from patients with type 2 Diabetes and Neuropathy Induce Autophagy and Colocalization with Mitochondria in SY5Y cells , 2005, Autophagy.

[47]  T. Hofmann,et al.  Isolation, structure determination, synthesis, and sensory activity of N-phenylpropenoyl-L-amino acids from cocoa (Theobroma cacao). , 2005, Journal of agricultural and food chemistry.

[48]  S. Simpson Of Mice . . . , 2004, Science.

[49]  E. Feldman,et al.  Oxidative stress in the pathogenesis of diabetic neuropathy. , 2004, Endocrine reviews.

[50]  I. Fridovich,et al.  Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. , 1998, Free radical biology & medicine.

[51]  K. Hall,et al.  Serum from patients with type 2 diabetes with neuropathy induces complement-independent, calcium-dependent apoptosis in cultured neuronal cells. , 1998, The Journal of clinical investigation.

[52]  H. Abrahamsson Gastrointestinal motility disorders in patients with diabetes mellitus , 1995, Journal of internal medicine.

[53]  L. Schiller,et al.  Disorders of gastrointestinal motility associated with diabetes mellitus. , 1983, Annals of internal medicine.